Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus
Open Access
- 1 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (11), 3343-3347
- https://doi.org/10.1128/aac.46.11.3343-3347.2002
Abstract
The MICs of triclosan for 31 clinical isolates of Staphylococcus aureus were 0.016 μg/ml (24 strains), 1 to 2 μg/ml (6 strains), and 0.25 μg/ml (1 strain). All the strains for which triclosan MICs were elevated (>0.016 μg/ml) showed three- to fivefold increases in their levels of enoyl-acyl carrier protein (ACP) reductase (FabI) production. Furthermore, strains for which triclosan MICs were 1 to 2 μg/ml overexpressed FabI with an F204C alteration. Binding studies with radiolabeled NAD+ demonstrated that this change prevents the formation of the stable triclosan-NAD+-FabI complex, and both this alteration and its overexpression contributed to achieving MICs of 1 to 2 μg/ml for these strains. Three novel, potent inhibitors of FabI (50% inhibitory concentrations, ≤64 nM) demonstrated up to 1,000-fold better activity than triclosan against the strains for which triclosan MICs were elevated. None of the compounds tested from this series formed a stable complex with NAD+-FabI. Consequently, although the overexpression of wild-type FabI gave rise to an increase in the MICs, as expected, overexpression of FabI with an F204C alteration did not cause an additional increase in resistance. Therefore, this work identifies the mechanisms of triclosan resistance in S. aureus, and we present three compounds from a novel chemical series of FabI inhibitors which have excellent activities against both triclosan-resistant and -sensitive clinical isolates of S. aureus.Keywords
This publication has 18 references indexed in Scilit:
- Discovery of a Novel and Potent Class of FabI-Directed Antibacterial AgentsAntimicrobial Agents and Chemotherapy, 2002
- Energetics of Side Chain Packing in Staphylococcal Nuclease Assessed by Exchange of Valines, Isoleucines, and LeucinesBiochemistry, 2001
- Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 2001
- Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discoveryDrug Discovery Today, 2001
- Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and HexachlorophenePublished by Elsevier BV ,2000
- Molecular basis for triclosan activity involves a flipping loop in the active siteProtein Science, 1999
- MOLMOL: A program for display and analysis of macromolecular structuresJournal of Molecular Graphics, 1996
- High-frequency transformation ofStaphylococcus aureus by electroporationCurrent Microbiology, 1990
- Contribution of hydrophobic interactions to protein stabilityNature, 1988
- [6] Statistical analysis of enzyme kinetic dataMethods in enzymology, 1979